Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biotricity Inc (NQ: BTCY ) 0.4631 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biotricity Inc < Previous 1 2 3 4 5 6 7 8 Next > Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure September 07, 2022 Via ACCESSWIRE Biotricity Reports Financial Results for Fiscal 2023 First Quarter August 15, 2022 Via ACCESSWIRE 12 Health Care Stocks Moving In Friday's After-Market Session August 05, 2022 Gainers Via Benzinga Biotricity to Host Fiscal First Quarter 2023 Financial Results Conference Call on August 15th at 4:30 p.m. ET August 05, 2022 Via ACCESSWIRE Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022 July 15, 2022 Via Benzinga Earnings Scheduled For August 15, 2022 August 15, 2022 Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. Via Benzinga Looking Into Biotricity's Return On Capital Employed July 15, 2022 According to Benzinga Pro data, during Q4, Biotricity (NASDAQ:BTCY) posted sales of $2.15 million. Earnings were up 21.07%, but Biotricity still reported an overall loss of $5.61 million. Via Benzinga Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year July 14, 2022 Company Reports Record Revenue and Improved Margins From Biotricity, Inc. Via AccessWire Exposures COVID-19 12 Health Care Stocks Moving In Tuesday's Intraday Session July 12, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 30, 2022 Via Benzinga Biotricity to Join Russell Microcap(R) Index June 23, 2022 REDWOOD CITY, CA / ACCESSWIRE / June 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that the... From Biotricity, Inc. Via AccessWire InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday June 29, 2022 Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. Via Benzinga 37 Stocks Moving In Thursday's Mid-Day Session June 16, 2022 Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares jumped 153% to $2.94 after the company announced it received notification of euro 782.1 million of funding from the Greek State for the... Via Benzinga 77 Biggest Movers From Yesterday June 01, 2022 Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 31, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Friday May 27, 2022 During Friday's session, 59 stocks hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session May 25, 2022 Gainers Via Benzinga Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th May 23, 2022 REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present... From Biotricity, Inc. Via AccessWire 71 Biggest Movers From Yesterday May 20, 2022 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... Via Benzinga Biotricity Issues Shareholder Update May 05, 2022 Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. From Biotricity, Inc. Via AccessWire Exposures COVID-19 Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022 March 22, 2022 - Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmias REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Biotricity, Inc.... From Biotricity, Inc. Via AccessWire Exposures Product Safety Biotricity Inc. (NASDAQ: BTCY) Featured in Virtual Coverage of the 34th Annual Roth Conference March 11, 2022 Via Investor Brand Network Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022 March 08, 2022 Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY)... From Biotricity, Inc. Via AccessWire Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022 March 07, 2022 Upgrades According to Brookline Capital, the prior rating for Intellia Therapeutics Inc (NASDAQ:NTLA) was changed from Hold to Buy. In the fourth quarter, Intellia Therapeutics... Via Benzinga Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th March 04, 2022 - Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position - Biotricity now taking preorders for Biotres, an FDA-cleared,... From Biotricity, Inc. Via AccessWire Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device February 23, 2022 - Announcement follows FDA clearance - Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY)... From Biotricity, Inc. Via AccessWire Exposures Product Safety Biotricity Releases Fiscal 2022 Third Quarter Financial Results February 14, 2022 Management to host investor call on Tuesday February 15th at 4:15 pm ET - 93% YOY Revenue Gains to $1.93 Million - Revenue Outpaces SG&A Increase by 2.2x - Cash Position of $16.8 Million at Quarter End... From Biotricity, Inc. Via AccessWire Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022 February 08, 2022 Management to host call on Tuesday, February 15th at 4:15pm ET Sees Calendar-2022 as a breakout year with commercial launch of Bioheart and FDA clearance for Biotres REDWOOD CITY, CA / ACCESSWIRE /... From Biotricity, Inc. Via AccessWire Exposures Product Safety Earnings Scheduled For February 14, 2022 February 14, 2022 Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million. Via Benzinga Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device January 24, 2022 Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion-dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022... From Biotricity, Inc. Via AccessWire Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.